Please Wait.....

Report

Europe Prefilled Syringes (Saline) Market

Market Report I 2025-10-01 I 350 Pages I Data Bridge Market Research

The Europe prefilled syringes (saline) market is expected to reach USD 288,447.40 thousand by 2032 from USD 138,585.78 thousand in 2024, growing at a CAGR of 9.7% in the forecast period of 2025 to 2032.

Market Segmentation:
Europe Prefilled Syringes (Saline) Market, By Type (Sterile Path Products and External Sterile Products), By Product Type (3 ML Prefilled Saline Syringes, 10 ML Prefilled Saline Syringes, 5 ML Prefilled Saline Syringes, 20 ML Prefilled Saline Syringes and Other Sizes), Material (Plastic Prefilled Syringes and Glass Prefilled Syringes), Usability (Disposable Prefilled Syringes and Reusable Prefilled Syringes), Design (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes and Customized Syringe Designs), Application (Flush Syringes, Emergency Care / Critical Care, Diagnostic Procedures and Other Applications), End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers and Homecare Settings), Distribution Channel (Direct Tenders / Group Purchasing Organizations, Distributors & Wholesalers, Retail Pharmacies, Online Pharmacies and Hospital Pharmacies), By Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, Czech Republic and Rest of Europe) Industry Trends and Forecast to 2032.
Overview of Europe Prefilled Syringes (Saline) Market Dynamics:

Driver
- Enhanced Safety and Efficiency of saline prefilLed syringes

Restraints
- Glass prefilled syringes are more susceptible to breakage

Opportunities
- Rise In Nosocomial Infections

Market Players:

The key players operating in the Europe Prefilled Syringes (Saline) Market are:
- B. Braun SE (Germany)
- BD (U.S.)
- Fresenius Kabi AG (Germany)
- MedXL Inc. (Canada)
- STI Group (Germany)
- Guerbet (France)
- Gerresheimer AG (Germany)
- SCHOTT Pharma (Germany)
- West Pharmaceutical Services, Inc. (U.S.)
- Stevanato Group (Italy)
- Vetter Pharma-Fertigung GmbH (Germany)
- NIPRO (Japan)
- Polymed. (India)
- Cardinal Health. (Canada)
- AptarGroup, Inc. (U.S.)
- Ypsomed (Switzerland)
- Nemera (France)
- Medline Industries, LP (U.S.)

TABLE OF CONTENTS
1 INTRODUCTION 58
1.1 OBJECTIVES OF THE STUDY 58
1.2 MARKET DEFINITION 58
1.3 OVERVIEW OF THE EMEA PREFILLED SYRINGES (SALINE) MARKET 58
1.4 CURRENCY AND PRICING 60
1.5 LIMITATIONS 60
1.6 MARKETS COVERED 60
2 MARKET SEGMENTATION 63
2.1 MARKETS COVERED 63
2.2 GEOGRAPHICAL SCOPE 64
2.3 YEARS CONSIDERED FOR THE STUDY 64
2.4 DBMR TRIPOD DATA VALIDATION MODEL 65
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 68
2.6 MULTIVARIATE MODELLING 69
2.7 MARKET APPLICATION COVERAGE GRID 70
2.8 PRODUCT LIFELINE CURVE 71
2.9 DBMR MARKET POSITION GRID: MANUFACTURER 72
2.10 DBMR MARKET POSITION GRID: DISTRIBUTOR 73
2.11 VENDOR SHARE ANALYSIS 74
2.12 SECONDARY SOURCES 75
2.13 ASSUMPTIONS 75
3 EXECUTIVE SUMMARY 76
4 PREMIUM INSIGHTS 81
4.1 PORTER'S FIVE FORCES ANALYSIS 83
4.2 BRAND OUTLOOK 84
4.2.1 BRAND COMPARATIVE ANALYSIS OF EMEA PREFILLED SYRINGES (SALINE) MARKET 84
4.2.2 PRODUCT VS BRAND OVERVIEW 85
4.2.3 PRODUCT OVERVIEW 85
4.2.4 BRAND OVERVIEW 85
4.3 CLIMATE CHANGE SCENARIO 86
4.3.1 ENVIRONMENTAL CONCERNS 86
4.3.2 INDUSTRY RESPONSE 86
4.3.3 GOVERNMENT'S ROLE 86
4.3.4 ANALYST RECOMMENDATIONS 87
?
4.4 INNOVATION TRACKER AND STRATEGIC ANALYSIS 88
4.4.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 88
4.4.1.1 JOINT VENTURES 88
4.4.1.2 MERGERS AND ACQUISITIONS 88
4.4.1.3 LICENSING AND PARTNERSHIP 88
4.4.1.4 TECHNOLOGY COLLABORATIONS 89
4.4.1.5 STRATEGIC DIVESTMENTS 89
4.4.2 NUMBER OF PRODUCTS IN DEVELOPMENT 90
4.4.3 STAGE OF DEVELOPMENT 90
4.4.4 TIMELINES AND MILESTONES 91
4.4.5 INNOVATION STRATEGIES AND METHODOLOGIES 91
4.4.6 RISK ASSESSMENT AND MITIGATION 92
4.4.7 FUTURE OUTLOOK 92
4.5 PATENT ANALYSIS - 94
4.5.1 GEOGRAPHIC TRENDS: 94
4.5.2 KEY APPLICANTS: 95
4.5.3 INVENTOR CONTRIBUTIONS: 95
4.5.4 TECHNOLOGICAL CLASSIFICATIONS (IPC CODES): 95
4.5.5 IMPLICATIONS FOR THE EMEA MARKET: 96
4.5.6 CONCLUSION: 96
4.6 RAW MATERIAL COVERAGE 97
4.6.1 CYCLIC OLEFIN POLYMER (COP) AND CYCLIC OLEFIN COPOLYMER (COC) 97
4.6.2 BOROSILICATE GLASS 97
4.6.3 SILICONE OIL (LUBRICATION COATING) 97
4.6.4 ELASTOMERIC RUBBER (PLUNGERS AND TIP CAPS) 98
4.6.5 STAINLESS STEEL (NEEDLES AND CANNULAS) 98
4.6.6 ADHESIVES AND LUBRICANTS (SECONDARY MATERIALS) 98
4.7 SUPPLY CHAIN ANALYSIS 99
4.7.1 OVERVIEW 99
4.7.2 LOGISTICS COST SCENARIO 100
4.7.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 100
4.7.4 END USERS 101
4.7.5 CONCLUSION 101
4.8 TECHNOLOGICAL ADVANCEMENTS - 102
4.9 VALUE CHAIN ANALYSIS 104
4.9.1 RAW MATERIALS & PRIMARY PACKAGING COMPONENTS 104
4.9.2 COMPONENT MANUFACTURING & FILL-FINISH (CONVERSION) 104
4.9.3 EQUIPMENT & TECHNOLOGY PROVIDERS 104
4.9.4 QUALITY, STANDARDS & REGULATORY INTERFACE 105
4.9.5 DISTRIBUTION, COLD-CHAIN & HOSPITAL SUPPLY LOGISTICS 105
4.9.6 CDMOS, R&D & LIFECYCLE MANAGEMENT (SERVICE LAYER) 105
4.9.7 END-USERS & USE CASES (HOSPITALS, HOMECARE, AMBULATORY) 106
4.9.8 CONCLUSION 106
4.10 VENDOR SELECTION CRITERIA - 107
4.11 PRICING ANALYSIS 109
5 TARIFFS & IMPACT ON THE MARKET 110
5.1 OVERVIEW 110
5.2 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 110
5.3 OUTLOOK: LOCAL PRODUCTION VS. IMPORT RELIANCE 111
5.4 VENDOR SELECTION CRITERIA DYNAMICS 112
5.5 IMPACT ON SUPPLY CHAIN 112
5.5.1 INTRODUCTION 112
5.5.2 RAW MATERIAL PROCUREMENT 113
5.5.3 MANUFACTURING AND PRODUCTION 113
5.5.4 LOGISTICS AND DISTRIBUTION 113
5.5.5 PRICE PITCHING AND POSITION OF MARKET 113
5.6 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 114
5.6.1 SUPPLY CHAIN OPTIMIZATION 114
5.6.2 JOINT VENTURE ESTABLISHMENTS 114
5.6.3 IMPACT ON PRICES 115
5.6.4 REGULATORY INCLINATION 116
5.6.4.1 GEOPOLITICAL SITUATION 116
5.6.5 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 117
5.6.5.1 FREE TRADE AGREEMENTS 117
5.6.5.2 ALLIANCES ESTABLISHMENTS 117
5.7 STATUS ACCREDITATION (INCLUDING MFN) 118
5.7.1 DOMESTIC COURSE OF CORRECTION 119
5.7.1.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 119
5.7.1.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES / INDUSTRIAL PARKS 119
5.8 CONCLUSION 120
6 EMEA PREFILLED SYRINGES (SALINE) MARKET: REGULATIONS 121
7 MARKET OVERVIEW 125
7.1 DRIVERS 127
7.1.1 ENHANCED SAFETY AND EFFICIENCY OF SALINE PREFILLED SYRINGES 127
7.1.2 ACCELERATED FLUSHING OF SALINE PREFILLED SYRINGES 128
7.1.3 COST-EFFECTIVENESS OF SALINE PREFILLED SYRINGES 129
7.1.4 GROWING EMPHASIS ON INFECTION PREVENTION AND CONTROL REGULATIONS 130
?
7.2 RESTRAINTS 131
7.2.1 GLASS PREFILLED SYRINGES ARE MORE SUSCEPTIBLE TO BREAKAGE 131
7.2.2 LIMITED COMPATIBILITY OF PREFILLED SYRINGES WITH IV SYSTEMS 132
7.3 OPPORTUNITIES 133
7.3.1 RISE IN NOSOCOMIAL INFECTIONS 133
7.3.2 RISE IN TELEHEALTH SERVICES 134
7.3.3 INCREASING PREVALENCE OF CHRONIC DISEASES 136
7.4 CHALLENGES 137
7.4.1 RISK OF CONTAMINATION OR ERROR DURING MANUFACTURING 137
7.4.2 SUPPLY SHORTAGE OF PREFILLED SALINE SYRINGE IN THE REGION 138
8 EMEA PREFILLED SYRINGES (SALINE) MARKET, BY TYPE 139
8.1 OVERVIEW 140
8.2 STERILE PATH PRODUCTS 144
8.2.1 3ML 145
8.2.2 10 ML 145
8.2.3 5 ML 145
8.2.4 20 ML 145
8.2.5 OTHERS 145
8.3 EXTERNAL STERILE PRODUCTS 146
8.3.1 3ML 147
8.3.2 10 ML 147
8.3.3 5 ML 147
8.3.4 20 ML 147
8.3.5 OTHERS 147
9 EMEA PREFILLED SYRINGES (SALINE) MARKET, BY PRODUCT TYPE 148
9.1 OVERVIEW 149
9.2 3ML PREFILLED SALINE SYRINGES 153
9.3 10 ML PREFILLED SALINE SYRINGES 153
9.4 5 ML PREFILLED SALINE SYRINGES 153
9.5 20 ML PREFILLED SALINE SYRINGES 153
9.6 OTHER SIZES 153
10 EMEA PREFILLED SYRINGES (SALINE) MARKET, BY MATERIAL 154
10.1 OVERVIEW 155
10.2 PLASTIC PREFILLED SYRINGES 158
10.3 GLASS PREFILLED SYRINGES 158
?
11 EMEA PREFILLED SYRINGES (SALINE) MARKET, BY USABILITY 159
11.1 OVERVIEW 160
11.2 DISPOSABLE PREFILLED SYRINGES 163
11.3 REUSABLE PREFILLED SYRINGES 163
12 EMEA PREFILLED SYRINGES (SALINE) MARKET, BY APPLICATION 164
12.1 OVERVIEW 165
12.2 FLUSH SYRINGES 169
12.3 EMERGENCY CARE / CRITICAL CARE 169
12.4 DIAGNOSTIC PROCEDURES 169
12.5 OTHER APPLICATIONS 169
13 EMEA PREFILLED SYRINGES (SALINE) MARKET, BY DESIGN 170
13.1 OVERVIEW 171
13.2 SINGLE-CHAMBER PREFILLED SYRINGES 174
13.3 DUAL-CHAMBER PREFILLED SYRINGES 175
13.4 CUSTOMIZED SYRINGE DESIGNS 175
14 EMEA PREFILLED SYRINGES (SALINE) MARKET, BY END USER 176
14.1 OVERVIEW 177
14.2 HOSPITALS 181
14.3 SPECIALTY CLINICS 181
14.4 AMBULATORY SURGICAL CENTERS 181
14.5 DIAGNOSTIC CENTERS 181
14.6 HOMECARE SETTINGS 181
15 EMEA PREFILLED SYRINGES (SALINE) MARKET, BY DISTRIBUTION CHANNEL 182
15.1 OVERVIEW 183
15.2 DIRECT TENDERS / GROUP PURCHASING ORGANIZATIONS 187
15.3 DISTRIBUTORS & WHOLESALERS 187
15.4 RETAIL PHARMACIES 187
15.5 ONLINE PHARMACIES 187
15.6 HOSPITAL PHARMACIES 187
?
16 EMEA PREFILLED SYRINGES (SALINE) MARKET BY REGION 188
16.1 EUROPE 191
16.1.1 GERMANY 203
16.1.2 FRANCE 213
16.1.3 U.K. 223
16.1.4 ITALY 233
16.1.5 SPAIN 243
16.1.6 RUSSIA 253
16.1.7 TURKEY 262
16.1.8 BELGIUM 271
16.1.9 DENMARK 280
16.1.10 NETHERLANDS 289
16.1.11 SWITZERLAND 299
16.1.12 SWEDEN 309
16.1.13 POLAND 319
16.1.14 NORWAY 328
16.1.15 FINLAND 337
16.1.16 CZECH REPUBLIC 346
16.1.17 REST OF EUROPE 355
16.2 MIDDLE EAST AND AFRICA 356
16.2.1 SOUTH AFRICA 367
16.2.2 SAUDI ARABIA 376
16.2.3 U.A.E. 385
16.2.4 BAHRAIN 394
16.2.5 KUWAIT 403
16.2.6 OMAN 412
16.2.7 QATAR 421
16.2.8 EGYPT 430
16.2.9 ISRAEL 439
16.2.10 REST OF MIDDLE EAST AND AFRICA 448
17 EMEA PREFILLED SYRINGES (SALINE) MARKET: COMPANY LANDSCAPE 449
17.1 COMPANY VALUE SHARE ANALYSIS: EMEA MANUFACTURERS 449
17.2 COMPANY VOLUME SHARE ANALYSIS: EMEA MANUFACTURERS 450
17.3 COMPANY SHARE ANALYSIS: EMEA DISTRIBUTORS 451
17.4 COMPANY VALUE SHARE ANALYSIS: GERMANY 452
17.5 COMPANY VOLUME SHARE ANALYSIS: GERMANY 453
17.6 COMPANY VALUE SHARE ANALYSIS: FRANCE 454
17.7 COMPANY VOLUME SHARE ANALYSIS: FRANCE 455
17.8 COMPANY VALUE SHARE ANALYSIS: U.K. 456
17.9 COMPANY VOLUME SHARE ANALYSIS: U.K. 457
17.10 COMPANY VALUE SHARE ANALYSIS: ITALY 458
17.11 COMPANY VOLUME SHARE ANALYSIS: ITALY 459
17.12 COMPANY VALUE SHARE ANALYSIS: SPAIN 460
17.13 COMPANY VOLUME SHARE ANALYSIS: SPAIN 461
17.14 COMPANY VALUE SHARE ANALYSIS: NETHERLANDS 462
17.15 COMPANY VOLUME SHARE ANALYSIS: NETHERLANDS 463
17.16 COMPANY VALUE SHARE ANALYSIS: BELGIUM 464
17.17 COMPANY VOLUME SHARE ANALYSIS: BELGIUM 465
17.18 COMPANY VALUE SHARE ANALYSIS: POLAND 466
17.19 COMPANY VOLUME SHARE ANALYSIS: POLAND 467
17.20 COMPANY VALUE SHARE ANALYSIS: CZECH REPUBLIC 468
17.21 COMPANY VOLUME SHARE ANALYSIS: CZECH REPUBLIC 469
17.22 COMPANY VALUE SHARE ANALYSIS: U.A.E. 470
17.23 COMPANY VOLUME SHARE ANALYSIS: U.A.E. 471
17.24 COMPANY VALUE SHARE ANALYSIS: ISRAEL 472
17.25 COMPANY VOLUME SHARE ANALYSIS: ISRAEL 473
17.26 COMPANY VALUE SHARE ANALYSIS: SOUTH AFRICA 474
17.27 COMPANY VOLUME SHARE ANALYSIS: SOUTH AFRICA 475
17.28 COMPANY VALUE SHARE ANALYSIS: SAUDI ARABIA 476
17.29 COMPANY VOLUME SHARE ANALYSIS: SAUDI ARABIA 477
18 SWOT ANALYSIS 478
19 COMPANY PROFILES DISTRIBUTOR 479
19.1 MEDLINE INDUSTRIES, LP 479
19.1.1 COMPANY SNAPSHOT 479
19.1.2 PRODUCT PORTFOLIO 479
19.1.3 RECENT DEVELOPMENT 482
19.2 MCKESSON CORPORATION 483
19.2.1 COMPANY SNAPSHOT 483
19.2.2 REVENUE ANALYSIS 483
19.2.3 PRODUCT PORTFOLIO 484
19.2.4 RECENT DEVELOPMENT 484
19.3 HENRY SCHEIN INC. 485
19.3.1 COMPANY SNAPSHOT 485
19.3.2 REVENUE ANALYSIS 485
19.3.3 PRODUCT PORTFOLIO 486
19.3.4 RECENT DEVELOPMENT 486
?
19.4 OWENS & MINOR 487
19.4.1 COMPANY SNAPSHOT 487
19.4.2 REVENUE ANALYSIS 487
19.4.3 PRODUCT PORTFOLIO 488
19.4.4 RECENT DEVELOPMENT 488
20 COMPANY PROFILES MANUFACTURER 489
20.1 B.BRAUN SE. 489
20.1.1 COMPANY SNAPSHOT 489
20.1.2 REVENUE ANALYSIS 490
20.1.3 PRODUCT PORTFOLIO 490
20.1.4 RECENT DEVELOPMENT 491
20.2 MEDXL INC 492
20.2.1 COMPANY SNAPSHOT 492
20.2.2 PRODUCT PORTFOLIO 492
20.2.3 RECENT DEVELOPMENT 493
20.3 BD 494
20.3.1 COMPANY SNAPSHOT 494
20.3.2 REVENUE ANALYSIS 495
20.3.3 PRODUCT PORTFOLIO 495
20.3.4 RECENT DEVELOPMENT 496
20.4 STI GROUP. 497
20.4.1 COMPANY SNAPSHOT 497
20.4.2 PRODUCT PORTFOLIO 497
20.4.3 RECENT DEVELOPMENT 498
20.5 FRESENIUS KABI AG (SUBSIDIARY OF FRESENIUS SE & CO. KGAA) 499
20.5.1 COMPANY SNAPSHOT 499
20.5.2 REVENUE ANALYSIS 499
20.5.3 PRODUCT PORTFOLIO 500
20.5.4 RECENT DEVELOPMENTS 500
20.6 APTARGROUP, INC. 501
20.6.1 COMPANY SNAPSHOT 501
20.6.2 REVENUE ANALYSIS 501
20.6.3 PRODUCT PORTFOLIO 502
20.6.4 RECENT DEVELOPMENT 502
20.7 CARDINAL HEALTH. 503
20.7.1 COMPANY SNAPSHOT 503
20.7.2 REVENUE ANALYSIS 503
20.7.3 PRODUCT PORTFOLIO 504
20.7.4 RECENT DEVELOPMENT 504
20.8 GERRESHEIMER AG 505
20.8.1 COMPANY SNAPSHOT 505
20.8.2 REVENUE ANALYSIS 505
20.8.3 PRODUCT PORTFOLIO 506
20.8.4 RECENT DEVELOPMENTS 507
20.9 GUERBET 508
20.9.1 COMPANY SNAPSHOT 508
20.9.2 REVENUE ANALYSIS 508
20.9.3 PRODUCT PORTFOLIO 509
20.9.4 RECENT DEVELOPMENT 510
20.10 MEDLINE INDUSTRIES, LP 511
20.10.1 COMPANY SNAPSHOT 511
20.10.2 PRODUCT PORTFOLIO 511
20.10.3 RECENT DEVELOPMENT 512
20.11 NEMERA 513
20.11.1 COMPANY SNAPSHOT 513
20.11.2 PRODUCT PORTFOLIO 513
20.11.3 RECENT DEVELOPMENT 513
20.12 NIPRO 514
20.12.1 COMPANY SNAPSHOT 514
20.12.2 REVENUE ANALYSIS 514
20.12.3 PRODUCT PORTFOLIO 515
20.12.4 RECENT DEVELOPMENT 515
20.13 POLYMED. 516
20.13.1 COMPANY SNAPSHOT 516
20.13.2 REVENUE ANALYSIS 516
20.13.3 PRODUCT PORTFOLIO 517
20.13.4 RECENT DEVELOPMENT 517
20.14 SCHOTT PHARMA 518
20.14.1 COMPANY SNAPSHOT 518
20.14.2 REVENUE ANALYSIS 518
20.14.3 PRODUCT PORTFOLIO 519
20.14.4 RECENT DEVELOPMENT 519
20.15 STEVANATO GROUP 521
20.15.1 COMPANY SNAPSHOT 521
20.15.2 REVENUE ANALYSIS 521
20.15.3 PRODUCT PORTFOLIO 522
20.15.4 RECENT DEVELOPMENT 522
?
20.16 VETTER PHARMA FERTIGUNG GMBH & CO. KG 523
20.16.1 COMPANY SNAPSHOT 523
20.16.2 PRODUCT PORTFOLIO 523
20.16.3 RECENT DEVELOPMENT 524
20.17 WEST PHARMACEUTICAL SERVICES INC 525
20.17.1 COMPANY SNAPSHOT 525
20.17.2 REVENUE ANALYSIS 525
20.17.3 PRODUCT PORTFOLIO 526
20.17.4 RECENT DEVELOPMENT 526
20.18 YPSOMED 527
20.18.1 COMPANY SNAPSHOT 527
20.18.2 REVENUE ANALYSIS 527
20.18.3 PRODUCT PORTFOLIO 528
20.18.4 RECENT DEVELOPMENT 528
21 QUESTIONNAIRE 529
22 RELATED REPORTS 533

Not Sure / Need Reassuring
- Confirm Content
  - Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
    
    Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
    
    Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
    
    Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
- Sample Pages
  - With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
    
    It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
    
    To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Check for Alternatives
  - Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
    
    To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
Prices / Formats / Delivery
- Prices
  - All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
    
    Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Discounts
  - As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
    
    Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
    
    To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Available Currencies
  - Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
    
    Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
    
    To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
- Licenses
  - License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Global Site License
  - The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
    
    It is important to note that this may exclude Parent Companies or Subsidiaries.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Formats
  - The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
    
    If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
- Delivery
  - Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
    
    Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
    
    If a delay in delivery is expected you will be informed about it immediately.
- Shipping Charges
  - As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
    
    If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
Ordering
- By Credit Card
  - We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
    
    Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
    
    For more information on PayU please visit: https://www.payu.pl/en/about-us
- By Money Transfer
  - If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
    
    With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
Security
- Website security
  - We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
    
    Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
- Credit Card Security
  - We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
    
    PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.